351 reports of this reaction
1.9% of all BETAMETHASONE DIPROPIONATE reports
#11 most reported adverse reaction
RASH is the #11 most commonly reported adverse reaction for BETAMETHASONE DIPROPIONATE. There are 351 FDA adverse event reports linking BETAMETHASONE DIPROPIONATE to RASH. This represents approximately 1.9% of all 18,714 adverse event reports for this drug.
Patients taking BETAMETHASONE DIPROPIONATE who experience rash should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RASH is a less commonly reported adverse event for BETAMETHASONE DIPROPIONATE, but still significant enough to appear in the safety profile.
In addition to rash, the following adverse reactions have been reported for BETAMETHASONE DIPROPIONATE:
The following drugs have also been linked to rash in FDA adverse event reports:
RASH has been reported as an adverse event in 351 FDA reports for BETAMETHASONE DIPROPIONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
RASH accounts for approximately 1.9% of all adverse event reports for BETAMETHASONE DIPROPIONATE, making it a notable side effect.
If you experience rash while taking BETAMETHASONE DIPROPIONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.